SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN DE0005227201
USD
  • Biotest
    Börse NYSE New York Stock Exchange
    ISIN DE0005227201 WKN: 522720
    Symbol BIO
    USD
  • Bio-Rad Laboratories
    Börse NYSE New York Stock Exchange
    ISIN US0905722072 WKN: 865406
    Symbol BIO-B
  • Bio-Rad Laboratories
    Börse NYSE New York Stock Exchange
    ISIN US0905722072 WKN: 865406
    Symbol BIO
  • Bio-Rad Laboratories
    Börse Xetra Frankfurt
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse München
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Stuttgart
    Symbol BIO
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Stuttgart
    Symbol BUWA
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Frankfurt
    Symbol BUWA
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse München
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Gettex System der Börse München
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Quotrix System der Börse Düsseldorf
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Düsseldorf
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Düsseldorf
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Börse Hamburg
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Gettex System der Börse München
    Symbol BIO
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Berlin
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Xetra Frankfurt
  • ISIN DE0005227235 WKN: 522723
    Symbol BIO3
    EUR
  • ISIN US0905722072
    Symbol BUWA
  • ISIN DE0005227201 WKN: 522720
    Symbol BIO
  • EUR
  • Symbol BIO
ISIN DE0005227201
WKN 522720
Symbol BIO
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Marktkapitalisierung 15.939.497.184 (+- 11%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

17.719.994.368 oder 14.159.000.000

Mitarbeiter 7.900 (+- 1%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

8.000 oder 7.800 Mitarbeiter

KGV 5.06
EBITDA 459.620.000
PEGRatio 1.0996
Buchwert 295.843

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 675 EUR -2,87% 

Aktionärsstruktur der Bio-Rad Laboratories, Inc

95 News & Informationen zur Bio-Rad Laboratories Aktie

  • Enzyme-linked Immunosorbent Assay (ELISA) Testing Market 2021-2025
    markets.businessinsider.com

    Enzyme-linked Immunosorbent Assay (ELISA) Testing Market 2021-2025

    NEW YORK, July 5, 2021 /PRNewswire/ — The enzyme-linked immunosorbent assay (ELISA) testing market is expected to grow by USD 265.55 million duri…

  • Worldwide COVID-19 Diagnostics Industry to 2025 - Featuring Abacus Diagnostica, Applied BioCode and BillionToOne Among Others
    markets.businessinsider.com

    Worldwide COVID-19 Diagnostics Industry to 2025 – Featuring Abacus Diagnostica, Applied BioCode and BillionToOne Among Others

    DUBLIN, July 5, 2021 /PRNewswire/ — The 'COVID-19 Diagnostics: Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country …

  • Worldwide Genomic Cancer Panel and Profiling Industry to 2025 - Featuring Anchor, Bioarray Genetics and Burning Rock Among Others
    markets.businessinsider.com

    Worldwide Genomic Cancer Panel and Profiling Industry to 2025 – Featuring Anchor, Bioarray Genetics and Burning Rock Among Others

    DUBLIN, July 5, 2021 /PRNewswire/ — The 'Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Sc…

  • Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
    globenewswire.com

    Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030

    In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…

  • Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
    globenewswire.com

    Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030

    In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…

  • Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
    globenewswire.com

    Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030

    In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…

  • 3 Strong Performers That Have Beat the Market
    gurufocus.com

    3 Strong Performers That Have Beat the Market

    GuruFocus Article or News written by Alberto Abaterusso and the topic is about: These stocks look like growth opportunities

  • Global High Content Screening Market (2021 To 2026) - Industry Trends, Share, Size, Growth, Opportunity And Forecasts
    thestreet.com

    Global High Content Screening Market (2021 To 2026) – Industry Trends, Share, Size, Growth, Opportunity And Forecasts

    DUBLIN, July 2, 2021 /PRNewswire/ — The “High Content Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • Global Genetic Testing Market (2020 to 2026) - Featuring Abbott Laboratories, 23andMe & Cepheid Among Others
    prnewswire.com

    Global Genetic Testing Market (2020 to 2026) – Featuring Abbott Laboratories, 23andMe & Cepheid Among Others

    /PRNewswire/ — The

  • Global Genetic Testing Market (2020 To 2026) - Featuring Abbott Laboratories, 23andMe & Cepheid Among Others
    thestreet.com

    Global Genetic Testing Market (2020 To 2026) – Featuring Abbott Laboratories, 23andMe & Cepheid Among Others

    DUBLIN, July 2, 2021 /PRNewswire/ — The

  • Global Liquid Biopsy Market Size to Reach $6.80 billion by 2028, At CAGR of 20.9%: Allied Market Research
    globenewswire.com

    Global Liquid Biopsy Market Size to Reach $6.80 billion by 2028, At CAGR of 20.9%: Allied Market Research

    Increase in incidences and prevalence of various cancer types, rise in demand for safe and non-invasive procedures, and advantages of liquid biopsy…

  • Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio
    prnewswire.com

    Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio

    /PRNewswire/ — The global autoimmune disease diagnostics market estimates it to grow by USD 1.98 billion during 2021-2025, with a CAGR of over 9% during the…

  • Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio
    prnewswire.com

    Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio

    /PRNewswire/ — The global autoimmune disease diagnostics market estimates it to grow by USD 1.98 billion during 2021-2025, with a CAGR of over 9% during the…

  • Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio
    prnewswire.com

    Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio

    /PRNewswire/ — The global autoimmune disease diagnostics market estimates it to grow by USD 1.98 billion during 2021-2025, with a CAGR of over 9% during the…

  • Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio
    markets.businessinsider.com

    Autoimmune Disease Diagnostics Market to grow by almost $ 2 Bn in Health Care Services Industry | Technavio

    NEW YORK, June 30, 2021 /PRNewswire/ –The global autoimmune disease diagnostics market estimates it to grow by USD 1.98 billion during 2021-2025,…

  • Bio Rad Laboratories : Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products
    marketscreener.com

    Bio Rad Laboratories : Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

    Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, today announced a partnership with Seegene, Inc., a global leader in multiplex molecular… | June 30, 2021

  • Global qPCR and dPCR Instrumentation Market 2021-2027 - Progress in Molecular Diagnostics Spur Demand for the Gene Amplification...
    markets.businessinsider.com

    Global qPCR and dPCR Instrumentation Market 2021-2027 – Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies

    DUBLIN, June 29, 2021 /PRNewswire/ — The 'qPCR and dPCR Instrumentation – Global Market Trajectory & Analytics' report has been added to Research…

  • Global Cell Surface Markers Market To Reach $1 Billion By 2026
    thestreet.com

    Global Cell Surface Markers Market To Reach $1 Billion By 2026

    SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026
    prnewswire.com

    Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Microplate Systems Market Worth $1,170 Million By 2026 - Exclusive Report By MarketsandMarkets™
    thestreet.com

    Microplate Systems Market Worth $1,170 Million By 2026 – Exclusive Report By MarketsandMarkets™

    CHICAGO, June 28, 2021 /PRNewswire/ — According to the new market research report ” Microplate Systems Market by Product (Microplate Reader (Multi-mode,

  • Hedge Funds Aren’t Crazy About Quest Diagnostics Incorporated (DGX) Anymore
    insidermonkey.com

    Hedge Funds Aren’t Crazy About Quest Diagnostics Incorporated (DGX) Anymore

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….

  • 10 Medical Device Stocks for 2021
    insidermonkey.com

    10 Medical Device Stocks for 2021

    In this article, we will take a look at some of the best medical device stocks for 2021. To skip our detailed analysis on the medical device industry,…

  • Hedge Funds Cashing Out Of ON Semiconductor Corporation (ON)
    insidermonkey.com

    Hedge Funds Cashing Out Of ON Semiconductor Corporation (ON)

    Is ON Semiconductor Corporation (NASDAQ:ON) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that…

  • Patient Blood Management Market Worth $ 15,848 Million by 2027 at 7.56% CAGR - Report by Market Research Future (MRFR)
    globenewswire.com

    Patient Blood Management Market Worth $ 15,848 Million by 2027 at 7.56% CAGR – Report by Market Research Future (MRFR)

    Patient Blood Management Market Insights and Industry Analysis by Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole…

  • Global Medical Biosensors Market Report 2021: Market was Valued at US$ 9.9 Billion in 2020 - Forecast to 2029
    markets.businessinsider.com

    Global Medical Biosensors Market Report 2021: Market was Valued at US$ 9.9 Billion in 2020 – Forecast to 2029

    DUBLIN, June 22, 2021 /PRNewswire/ — The 'Medical Biosensors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Ke…

  • Global Medical Biosensors Market Report 2021: Market was Valued at US$ 9.9 Billion in 2020 - Forecast to 2029
    prnewswire.com

    Global Medical Biosensors Market Report 2021: Market was Valued at US$ 9.9 Billion in 2020 – Forecast to 2029

    /PRNewswire/ — The “Medical Biosensors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies…

  • Global Digital PCR Market (2021 to 2028) - by Technologies, Product Type, Application and End-user
    markets.businessinsider.com

    Global Digital PCR Market (2021 to 2028) – by Technologies, Product Type, Application and End-user

    DUBLIN, June 21, 2021 /PRNewswire/ — The 'Digital PCR Market by Technologies, Product Type, Application and End User: Global Opportunity Analysis…

  • Gentex and Logitech Show High Profit, Low Debt
    gurufocus.com

    Gentex and Logitech Show High Profit, Low Debt

    GuruFocus Article or News written by John Dorfman and the topic is about: Such stocks have a margin of safety

  • Bio Rad Laboratories : Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing
    marketscreener.com

    Bio Rad Laboratories : Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing

    Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, today announced the launch of its PREvalence™ ddPCR® SARS-CoV-2 Wastewater… | June 21, 2021

  • Bio-Rad Launches Its PREvalence DdPCR SARS-CoV-2 Wastewater Quantification Kit For COVID-19 Wastewater Testing
    thestreet.com

    Bio-Rad Launches Its PREvalence DdPCR SARS-CoV-2 Wastewater Quantification Kit For COVID-19 Wastewater Testing

    Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its

  • Nvidia and Adobe Lead Off My 30-30 Club
    gurufocus.com

    Nvidia and Adobe Lead Off My 30-30 Club

    Nvidia and Adobe Lead Off My 30-30 Club, Stocks: NVDA,ADBE,INTU,LRCX,ZTS,NSP,CTXS,BJ,TPX,MED,BIO,FT, release date:Apr 12, 2021

  • Plasma Fractionation Market to Reach $41.4 Billion by 2027, Growing at a CAGR of 7% From 2020 With COVID-19 Impact - Meticulous Research®...
    benzinga.com

    Plasma Fractionation Market to Reach $41.4 Billion by 2027, Growing at a CAGR of 7% From 2020 With COVID-19 Impact – Meticulous Research® Analysis

    London, Jan. 14, 2021 (GLOBE NEWSWIRE) — In its latest publication, titled “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, …

  • Global High Throughput Process Development Market Will Reach USD 715 Million by 2026: Facts & Factors
    benzinga.com

    Global High Throughput Process Development Market Will Reach USD 715 Million by 2026: Facts & Factors

    New York, NY, Jan. 13, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “High Throughput Process Development Market By …

  • Global Blood Cell Separation Market – Rising incidence of cancer is encouraging further research in the field, Advances in computer...
    benzinga.com

    Global Blood Cell Separation Market – Rising incidence of cancer is encouraging further research in the field, Advances in computer techniques etc. driving market growth – by PMI

    Covina, CA, Jan. 12, 2021 (GLOBE NEWSWIRE) — The market is driven by the increasing use of cell separation in cancer research. In addition, the rising …

  • A Trio of High Earnings Return Stocks
    gurufocus.com

    A Trio of High Earnings Return Stocks

    A Trio of High Earnings Return Stocks, Stocks: BIO,SUPN,FVE, release date:Jan 10, 2021

  • In-Vitro Diagnostics Market by Product & Service, Technology, Application and End-user - Global Forecast to 2025
    benzinga.com

    In-Vitro Diagnostics Market by Product & Service, Technology, Application and End-user – Global Forecast to 2025

    Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) — The “In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, …

  • Insights on Global Plasma Therapy Market Size & Share Will Reach USD 495 Million by 2026: Facts & Factors
    benzinga.com

    Insights on Global Plasma Therapy Market Size & Share Will Reach USD 495 Million by 2026: Facts & Factors

    New York, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Plasma Therapy Market Type (Pure PRP, …

  • Global Oncology Precision Medicine Market (2020 to 2030) - Analysis and Forecast
    benzinga.com

    Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast

    Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …

  • Robot Portfolio Chugs Along, Seeking to Regain Past Glory
    gurufocus.com

    Robot Portfolio Chugs Along, Seeking to Regain Past Glory

    Robot Portfolio Chugs Along, Seeking to Regain Past Glory, Stocks: CNNE,AEL,IMKTA,FF,UNM,REGI,WOR,BIO,PDM,HUN, David Dreman, release date:Jan 04, 2021

  • Global Clinical Microbiology Instruments and Reagents Market 2020-2027: Market Size to Reach $6.1 Billion - COVID-19 Serology Race is...
    benzinga.com

    Global Clinical Microbiology Instruments and Reagents Market 2020-2027: Market Size to Reach $6.1 Billion – COVID-19 Serology Race is Getting Bigger and Faster

    Dublin, Jan. 04, 2021 (GLOBE NEWSWIRE) — The “Clinical Microbiology Instruments and Reagents – Global Market Trajectory & Analytics” report has …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Bio-Rad Laboratories Aktie

Das Unternehmen Bio-Rad Laboratories, Inc aus USA beschäftigt 7.900 Mitarbeiter und ist in den Bereichen Chemie & Pharma, LifeScience, Medizinische Produkte / Medizintechnik, Gerätehersteller, Biotechnologie, Pharma tätig.

Das Unternehmen Bio-Rad Laboratories, Inc ist in mehr als 45 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Healthcare Innovation  UCITS  ETF gewichtet Bio-Rad Laboratories mit 1,13% im ETF.

Entdecke die 6 ETFs in denen Bio-Rad Laboratories, Inc am höchsten gewichtet ist Insgesamt in 45 ETFs enthalten

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero